Martin Elišák

B-cell targeted therapy to impact the progression of multiple sclerosis

M. Elišák, Martin Elišák, 2023, Neurologie pro praxi.

Risk of Seizure Recurrence Due to Autoimmune Encephalitis With NMDAR, LGI1, CASPR2, and GABABR Antibodies

S. Ramanathan, M. Titulaer, J. D. de Vries, 2024, Neurology(R) neuroimmunology & neuroinflammation.

The prevalence of neural antibodies in temporal lobe epilepsy and the clinical characteristics of seropositive patients

P. Marusic, C. Bien, F. Leypoldt, 2018, Seizure.

Paraneoplastic or not? Sirtuin 2 in anti‐N‐methyl‐d‐aspartate receptor encephalitis

R. Constantinescu, J. Hanzalová, M. Elišák, 2023, European journal of neurology.

Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid

A. Šedivá, P. Marusic, V. Komarek, 2016, Journal of Neuroinflammation.

Epilepsy surgery in drug resistant temporal lobe epilepsy associated with neuronal antibodies

N. Bargalló, P. Marusic, M. Sperling, 2017, Epilepsy Research.